Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jan 1;1(4):306-16.

Update on pancreatic intraepithelial neoplasia

Affiliations

Update on pancreatic intraepithelial neoplasia

Ralph H Hruban et al. Int J Clin Exp Pathol. .

Abstract

Pancreatic intraepithelial neoplasia (PanIN) is a histologically well-defined precursor to invasive ductal adenocarcinoma of the pancreas. PanINs are remarkably common lesions, particularly in the elderly population. Molecular studies have helped establish the progression of PanIN to invasive cancer, and recently genetically engineered mouse models have been generated that recapitulate the entire spectrum of lesions from precursor to invasive pancreatic cancer. Some PanIN lesions produce lobulocentric atrophy of the pancreatic parenchyma, and, when multifocal, this lobulocentric atrophy may be detectable using currently available imaging techniques such as endoscopic ultrasound. The association of acinar-ductal metaplasia with PanIN lesions has led some to hypothesize that PanINs develop from acinar cells that undergo acinar-ductal metaplasia.

Keywords: Pancreatic cancer; epigenetics; genetics; intraepithelial neoplasm; metaplasia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The progression from normal ducts (A) to pancreatic intraepithelial neoplasia (PanIN) (B-D) is associated with both architectural and cytological changes. In PanIN-1 the nuclei are uniform and basally oriented (B). The nuclei in PanIN-2 are slightly larger, more basophilic and there is some loss of nuclear polarity (C). The nuclear pleomorphism in PanIN-3 can be significant (D).
Figure 2
Figure 2
Model for the histological and genetic progression from normal cells (far left) through PanIN lesions (center), to invasive pancreatic cancer (far right). (Reprinted, with permission, from Annual Review of Pathology: Mechanisms of Disease. 2008;3:157–188 © by Annual Reviews. www.annualreviews.org).

Similar articles

Cited by

References

    1. American Cancer Society. Cancer. New York, New York: American Cancer Society; 2007. Cancer Facts and Figures 2007; pp. 1–52.
    1. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784–1792. - PubMed
    1. Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, Dassonville F, Bonithon-Kopp C. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004;126:1674–1680. - PubMed
    1. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000;284:1954–1961. - PubMed
    1. Newcomb PA, Storer BE, Morimoto LM, Templeton A, Potter JD. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst. 2003;95:622–625. - PubMed

LinkOut - more resources